Technology
Health
Pharmaceutical

Jaguar Health

$1.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-8.26%) Today
+$0.08 (7.21%) As of 5:46 PM EDT after-hours

Why Robinhood?

You can buy or sell Jaguar Health and other stocks, options, ETFs, and crypto commission-free!

About JAGX

Jaguar Health, Inc. Common Stock, also called Jaguar Health, is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Read More Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

Employees
40
Headquarters
San Francisco, California
Founded
2013
Market Cap
47.07M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
572.25K
High Today
$1.27
Low Today
$1.01
Open Price
$1.22
Volume
858.68K
52 Week High
$175.00
52 Week Low
$1.00

Collections

Technology
Health
Pharmaceutical
Advertising and Marketing
Therapy
Business Services
2015 IPO
US

JAGX Earnings

-$9.09
-$6.08
-$3.06
-$0.05
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$9.09 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.